It is a pharma private limited company based in Ambernath, Maharashtra, India, established in 2006.
2006 | Ambernath, Maharashtra, India | ActiveSequel Pharmaceuticals (India) Private Limited, a active private limited company, was established on 28 June 2006 in Ambernath, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MH2006PTC162896. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.80 Cr.
Formerly known as Sequel Pharmachem Private Limited, Sequel Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Ramchandra Haridas Parade (Director), Nandadip Sakharam Rasam (Director). Past directors included Mohan Kashiram Kadam, Satish Vithhal Sawant, Santosh Shrikrishna Joshi. It holds ₹5.00 Cr open charges and ₹36.09 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at N-46, Ambernath Midc, Anand Nagar,, Ambernath, Maharashtra, 421504.
U24239MH2006PTC162896
162896
28 June 2006
₹6.00 Cr
₹5.80 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sequel Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramchandra Haridas Parade | Director | 18 Jun 2020 | Current |
| Nandadip Sakharam Rasam | Director | 06 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Jun 2020 | Past |
| Pramod Abcsdd | Director | 06 Apr 2010 | Past |
| Pramod Abcsdd | Director | 08 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Director | 02 Jan 2008 | Past |
| Pramod Abcsdd | Director | 02 Jan 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sequel Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 95.55% increase in profit. The company's net worth dipped by a decrease of 0.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sequel Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹360,925,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2011 | Nkgsb Co-Op. Bank Ltd. | ₹5.00 Cr | Open |
| 22 Dec 2007 | Corporation Bank | ₹29.31 Cr | Satisfied |
| 10 Aug 2007 | Janakalyan Sahakari Bank Ltd. | ₹4.18 Cr | Satisfied |
| 12 Apr 2007 | Janakalyan Sahakari Bank Limited | ₹1.60 Cr | Satisfied |
| 12 Apr 2007 | Janakalyan Sahakari Bank Ltd. | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sequel Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sequel Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequel Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sequel Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Sequel Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Nandadip Sakharam Rasam was appointed as a Director was appointed as a Director on 06 May 2023 & has been associated with this company since 2 years 6 months . was recorded as a recent event.
Progress on Ramchandra Haridas Parade was appointed as a Director was appointed as a Director on 18 Jun 2020 & has been associated with this company since 5 years 5 months . was documented.
A charge registered on 10 Aug 2007 via Charge ID 10063597 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 07 Jun 2017. was recorded as a recent event.
A charge registered on 12 Apr 2007 via Charge ID 10096643 with Janakalyan Sahakari Bank Limited was fully satisfied on 07 Jun 2017. was recorded as a recent event.
The CIN of Sequel Pharmaceuticals (India) Private Limited is U24239MH2006PTC162896.
Sequel Pharmaceuticals (India) Private Limited is headquartered at N-46, Ambernath Midc, Anand Nagar,, Ambernath, Maharashtra, 421504.
Sequel Pharmaceuticals (India) Private Limited was incorporated on 28 June 2006.
The current directors of Sequel Pharmaceuticals (India) Private Limited are
The primary industry of Sequel Pharmaceuticals (India) Private Limited is Pharma.
Sequel Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Sequel Pharmaceuticals (India) Private Limited is ₹6.00 Cr, and the paid-up capital is ₹5.80 Cr.
The compliance status of Sequel Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX